Lisata Therapeutics (LSTA) Stock: Buy, Sell, or Hold?
LSTA - Lisata Therapeutics, Inc. Common Stock
$0.99
-0.07 (-6.46%)
âŧ
5d:
-1.83%
30d:
-15.26%
90d:
-6.46%
WAIT
LOW Confidence
Analysis Updated: Nov 5, 2026 12:00 AM ET
Earnings: Nov 05, 2026
0d
Get Alerted When LSTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: LSTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: LSTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: LSTA is currently trading at $0.99, which is considered slightly low relative to its 30-day fair value range of $0.97 to $1.30.
Technical Outlook: Technically, LSTA is in a strong downtrend. Immediate support is located at $0.96, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: LSTA scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+303.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LSTA is in a strong downtrend. Immediate support is located at $0.96, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: LSTA scores 77/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $4.00 (+303.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.97 -
$1.30
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (77/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BULLISH: Trading 303.4% below Wall St target ($4.00)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.97 -
$1.30
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.96
Resistance Level
$1.15
Current Trend
Strong Downtrend
Technical data as of
Nov 5, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.85
Wall Street Target
$4.00
(+303.4%)
Revenue Growth (YoY)
-90.0%
Share & Embed Analysis
Last updated: November 06, 2026 5:32 AM ET
Data refreshes hourly during market hours. Next update: 6:32 AM
Data refreshes hourly during market hours. Next update: 6:32 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LSTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
23 analysts |
$107 | 53 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 33 SELL |
|
MDGL
Madrigal PharmaceuticalsâĻ |
STRONG BUY
19 analysts |
$685 | 47 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 55 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 64 BUY |
